MASOLA, Valentina
 Distribuzione geografica
Continente #
EU - Europa 1.879
NA - Nord America 1.587
AS - Asia 991
SA - Sud America 161
AF - Africa 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.637
Nazione #
US - Stati Uniti d'America 1.561
RU - Federazione Russa 756
GB - Regno Unito 401
SG - Singapore 394
CN - Cina 354
IT - Italia 169
SE - Svezia 126
BR - Brasile 124
FR - Francia 110
HK - Hong Kong 88
IE - Irlanda 86
FI - Finlandia 81
DE - Germania 77
VN - Vietnam 66
UA - Ucraina 23
AR - Argentina 20
ID - Indonesia 17
BE - Belgio 13
IN - India 11
AT - Austria 10
KR - Corea 9
MX - Messico 9
BD - Bangladesh 8
CA - Canada 8
IL - Israele 7
ZA - Sudafrica 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CO - Colombia 4
EC - Ecuador 4
ES - Italia 4
JP - Giappone 4
PL - Polonia 4
TR - Turchia 4
VE - Venezuela 4
CL - Cile 3
IQ - Iraq 3
LB - Libano 3
MA - Marocco 3
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
TN - Tunisia 2
AL - Albania 1
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.637
Città #
Southend 355
Chandler 271
Moscow 271
Singapore 145
Jacksonville 136
Woodbridge 130
Dallas 107
Ashburn 98
Ann Arbor 96
Hong Kong 87
Dublin 84
Beijing 78
Houston 47
Wilmington 40
Lawrence 37
Princeton 37
New York 34
Los Angeles 25
Nanjing 22
Redondo Beach 21
Columbus 20
Dong Ket 20
Shenyang 20
Jinan 19
Helsinki 18
Redmond 17
The Dalles 17
Verona 17
Buffalo 14
Munich 14
Brussels 13
São Paulo 13
Tianjin 13
Council Bluffs 12
Ho Chi Minh City 11
Jakarta 11
Seattle 11
Hebei 10
Milan 10
Santa Clara 10
Vienna 10
Boardman 9
Taizhou 9
Guangzhou 8
Jiaxing 8
Ningbo 8
Brooklyn 7
Chicago 7
Denver 7
Nanchang 7
Padova 7
Phoenix 7
Rome 7
Hanoi 6
Turku 6
Zhengzhou 6
Fairfield 5
Hangzhou 5
Johannesburg 5
San Francisco 5
Sindelfingen 5
Stockholm 5
Auburn Hills 4
Catanzaro 4
Changsha 4
Frankfurt am Main 4
Genova 4
Kochi 4
Lancaster 4
Montreal 4
Norwalk 4
Querétaro 4
Rio de Janeiro 4
Seoul 4
Shanghai 4
Tokyo 4
Warsaw 4
Cabo Frio 3
Campinas 3
Chennai 3
Conselheiro Lafaiete 3
Detroit 3
Florence 3
Fuzhou 3
Governador Valadares 3
Haikou 3
Kent 3
London 3
Novokuznetsk 3
Quito 3
Redwood City 3
Taiyuan 3
Tel Aviv 3
Atlanta 2
Baku 2
Bishkek 2
Biên Hòa 2
Bogotá 2
Boston 2
Bragado 2
Totale 2.682
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 229
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 221
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 178
mTOR inhibitors and renal allograft: Yin and Yang. 161
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 160
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 157
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 155
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 152
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 151
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. 149
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 146
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 142
Sulodexide and glycosaminoglycans in the progression of renal disease. 140
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 139
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 133
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 129
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 126
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 126
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 125
Heparanase as a target in cancer therapy. 123
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 121
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 121
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 120
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 120
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells. 115
Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells 115
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion 113
Heparanase: another renal player controlled by vitamin d. 111
L: -citrulline Prevents Alveolar and Vascular Derangement in a Rat Model of Moderate Hyperoxia-induced Lung Injury. 102
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 102
Endothelial Glycocalyx as a Regulator of Fibrotic Processes 96
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer. 88
The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells 86
LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase 85
Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. 74
Impact of heparanase on renal fibrosis. 73
Role of Heparanase in Tumor Progression: Molecular Aspects and Therapeutic Options 50
Totale 4.734
Categoria #
all - tutte 16.087
article - articoli 15.461
book - libri 0
conference - conferenze 626
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 37 26 11 9 5 3 33 45
2021/2022280 26 48 4 54 4 9 10 22 7 8 17 71
2022/2023673 51 92 65 103 64 137 15 39 80 4 16 7
2023/2024255 16 25 25 12 32 42 9 19 1 17 45 12
2024/2025740 45 43 30 131 33 30 47 35 118 30 67 131
2025/20261.335 162 95 110 372 596 0 0 0 0 0 0 0
Totale 4.734